Vascular Biogenics Ltd (VBLT)

[Oren1976]

I also want success but there is a motive of fear throughout this ph3 . Fear of failure. The change of trigger from 91 events to 105 plus the other condition and then the fact company asked fda to cancel futility .It is a motive that repeat itself in various ways. I see now sadly in inspire and other sources people on vb111 arm that die after 8 9 or 10 months. Don't be so sure vb111 is doing so great. I think vb111 struggle because we talk about rgbm. I still believe there is small group that vb111 works very well for them even to an extent of tumor disappearing and this is why the fda agreed to cancel futility and agreed to change protocol to 189 events...of course I can be wrong but I think vb111 will be approved based on more than usual complete responders